• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Akums Drugs and Pharmaceuticals Limited — Board Meeting, 13-02-2026: Outcome of Board Meeting

    13-02-2026 | 04:18 pm

    Akums Drugs' board approved consolidated Q3 FY26 results. Revenue reached ₹1,159.59 Cr, and profit was ₹67.67 Cr. Earnings per share for the quarter stood at ₹4.33.

    No comments yet. Be the first to comment!

    All announcements from Akums Drugs and Pharmaceuticals Limited